arofylline derivatives (Almirall)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namearofylline derivatives (Almirall)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodieterase 4 inhibitors

TargetsPhosphodieterase 4

Therapy Area/IndicationsInflammationAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlmirall Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAlmirall Sa

Active IndicationsN/A

Inactive IndicationsInflammationAsthma

ATC CodeN/A